Long	B:C2982391
noncoding	I:C2982391
RNA	I:C2982391

X	B:C3273444
inactivate	I:C3273444
-	I:C3273444
specific	I:C3273444
transcript	I:C3273444
acts	O
as	O
an	O
oncogene	B:C0029016
in	O
non-small	B:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
by	O
epigenetically	B:C3494434
repressing	I:C3494434
KLF2	B:C1456423
expression	B:C1171362
.	O

Recently	O
,	O
long	B:C2982391
noncoding	I:C2982391
RNAs	I:C2982391
(	O
long	B:C2982391
noncoding	I:C2982391
RNAs	I:C2982391
)	O
have	O
been	O
identified	O
as	O
critical	O
regulators	B:C0017362
in	O
numerous	O
types	O
of	O
cancers	B:C0006826
,	O
including	O
non-small	B:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
(	O
non	B:C0007131
-	I:C0007131
small	I:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
)	O
.	O

X	B:C3273444
inactivate	I:C3273444
-	I:C3273444
specific	I:C3273444
transcript	I:C3273444
(	O
X	B:C3273444
inactivate	I:C3273444
-	I:C3273444
specific	I:C3273444
transcript	I:C3273444
)	O
has	O
been	O
found	O
to	O
be	O
up	B:C0041904
-	I:C0041904
regulated	I:C0041904
and	O
acts	O
as	O
an	O
oncogene	B:C0029016
in	O
gastric	B:C0699791
cancer	I:C0699791
and	O
hepatocellular	B:C2239176
carcinoma	I:C2239176
,	O
but	O
little	O
is	O
known	O
about	O
its	O
expression	B:C1171362
pattern	B:C0449774
,	O
biological	B:C3714634
function	I:C3714634
and	O
underlying	O
mechanism	O
in	O
non-small	B:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
.	O

Here	O
,	O
we	O
identified	O
X	B:C1571617
inactivate	I:C1571617
-	I:C1571617
specific	I:C1571617
transcript	I:C1571617
as	O
an	O
oncogenic	B:C0029016
lncRNA	B:C2982391
by	O
driving	O
tumorigenesis	B:C0596263
in	O
non-small	B:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
.	O

We	O
found	O
that	O
X	B:C1571617
inactivate	I:C1571617
-	I:C1571617
specific	I:C1571617
transcript	I:C1571617
is	O
over	O
-	O
expressed	B:C0040649
in	O
non-small	B:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
,	O
and	O
its	O
increased	O
level	O
is	O
associated	O
with	O
shorter	B:C1850775
survival	I:C1850775
and	O
poorer	B:C0278252
prognosis	I:C0278252
.	O

Knockdown	B:C2350567
of	O
X	B:C1571617
inactivate	I:C1571617
-	I:C1571617
specific	I:C1571617
transcript	I:C1571617
impaired	O
non-small	B:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
cells	B:C0596290
proliferation	I:C0596290
,	O
migration	B:C1622501
and	O
invasion	B:C2699153
in	O
vitro	O
,	O
and	O
repressed	O
the	O
tumorigenicity	B:C1519697
of	O
non-small	B:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
cells	O
in	O
vivo	O
.	O

Mechanistically	O
,	O
RNA	B:C0035668
immune	B:C0021069
-	I:C0021069
precipitation	I:C0021069
(	O
RNA	B:C0021069
immune	I:C0021069
-	I:C0021069
precipitation	I:C0021069
)	O
and	O
RNA	B:C0035668
pull	B:C0681814
-	I:C0681814
down	I:C0681814
experiment	I:C0681814
demonstrated	O
that	O
X	B:C1571617
inactivate	I:C1571617
-	I:C1571617
specific	I:C1571617
transcript	I:C1571617
could	O
simultaneously	O
interact	O
with	O
EZH2	B:C1172384
to	O
suppress	O
transcription	B:C0040649
of	O
its	O
potential	O
target	O
KLF2	B:C1456423
.	O

Additionally	O
,	O
rescue	O
experiments	B:C0681814
revealed	O
that	O
X	B:C1571617
inactivate	I:C1571617
-	I:C1571617
specific	I:C1571617
transcript	I:C1571617
's	O
oncogenic	B:C0029016
functions	O
were	O
partly	O
depending	O
on	O
silencing	B:C0598496
KLF2	B:C1456423
expression	B:C1171362
.	O

Collectively	O
,	O
our	O
findings	B:C0243095
expound	O
how	O
X	B:C1571617
inactivate	I:C1571617
-	I:C1571617
specific	I:C1571617
transcript	I:C1571617
over	O
-	O
expression	B:C0040649
endows	O
an	O
oncogenic	B:C0029016
function	O
in	O
non-small	B:C0007131
cell	I:C0007131
lung	I:C0007131
cancer	I:C0007131
.	O

